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28.1 INTRODUCTION
In general, scaffolds should be prepared with biocompatible materials, and if possi-
ble, already approved for clinical use. One of the crucial properties that can determine
cell ingrowth, proliferation within the scaffolds and integration with the surrounding
tissues is the 3D porous structure of the scaffolds [1]. It is also reported that an ideal
scaffold for tissue engineering should be extremely porous and present a very inter-
connected pore network which allows nutrients and metabolic waste to flow [2]. The
porous structure also contributes to provide cells the appropriate nutritional condi-
tions and spatial organization for tissue regeneration [3], as well as providing a 3D
environment for cell culture that is pivotal for their phenotype development and sta-
bility in vitro [4]. The scaffold should also degrade at the same time that of the tissue,
without releasing toxic or inhibitory products. The mechanical properties of a scaf-
fold should also be addressed, as they should match those of the native tissue being
repaired, and the mechanical integrity should be maintained as long as needed for the
integration of the newly formed tissue [5].
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In vitro testing is performed before in vivo assays, as the newly developedmaterials
can be examined outside of the body, the results are more reproducible, and more
materials/conditions can be tested. The biocompatibility of any biomaterials should
be evaluated in order to describe its strengths and feasibility for clinical manipulation
[6]. So, preliminary in vitro tests are always carried out to screen and characterize the
effects of a biomaterial or medical device prior its commercialization for humans [7].
28.2 CYTOTOXICITY ASSAYS
In vitro models for testing the biocompatibility of biomaterials and their derivatives
are used to illustrate the hidden toxic effects of leachable materials or derivatives,
such as catalysts, residual monomers or other polymer erosion products [6]. For
example, the MEM extract test is designed to determine the rate of cytotoxicity of
leachable materials released from medical materials or devices. In this method, cells
are cultured with an extract prepared from the potential leachable material. After
several time periods, the effect of the leachable materials on cells is assessed, evalu-
ating parameters such as cell growth, metabolism, cell membrane damage, etc. The
method is simple: a monolayer of cells is cultured with an extract of the medical
material/device to be tested. The cells response along the time of reaction is then
evaluated. If the extract contains toxic leachable materials originated from the med-
ical material/device, cells will react. Therefore, cell growth inhibition, decrease or
increase of metabolism, cell death, intracellular granulation and/ or change in cell
morphology can be observed. The rate of cell damage is qualitatively and quantita-
tively established by a cytotoxicity index. When the value exceeds a certain level,
the material or device fails the test. Cytotoxicity assays measure only effects on
cells during the first 12 to 24 hours after exposure to toxic substances. However,
many biological reactions in vivo are not simply cytotoxic and are propagated beyond
24 hours [6].
28.3 EVALUATION OF CELL MORPHOLOGY AND DISTRIBUTION
28.3.1 Scanning Electron Microscopy (SEM)
Scanning electron microscopy (SEM) is a microscopic method extremely valuable in
polymeric materials and structures, along with many other research areas [8]. Its main
attributes are that it reveals the 3D topography of the specimen examined and its mag-
nification could be extremely high. SEM provides a direct assessment of pore size and
structure. Interconnectivity of a scaffold can also be estimated, as well as examination
of scaffold interior by sectioning the specimens. For polymeric structures, high mag-
nifications are generally not possible because of the intensity of the electron beams
damaging the thin polymeric samples, which generally leads to deformation and even
melting of the specimen. To overcome this problem, polymeric samples are usually
coated with conductive materials such as gold.
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FIGURE 28.1 Human bone marrow mesenchymal stem cells cultured on chitosan-
polybutylene succinate scaffolds for 7 days in osteogenic differentiated conditions.
28.3.2 Fluorescence Microscopy
In parallel to this indirect observation, the constructs can be analyzed by fluorescence
microscopy. In this technique, the biological molecules are labeled with a fluorescent
marker and detected visually, usually by selecting an appropriated wavelength [9].
One advantage of the fluorescence microscopy is the fact that some dyes quench the
fluorescence of another dye by the so-called Fo¨rster energy transfer. Another advan-
tage is that the environment influences the fluorescence wavelength; this can also
be used to get more insight in the structural properties of a biomolecule. In other
fluorescence-based microscopy, specifically in confocal microscopy, a laser beam is
split and refocused just on the plane of interest [9]. This reduces one problem of nor-
mal fluorescencemicroscopywhere the entire sample is illuminated and both in-focus
and out-of-focus points contribute equally to the signal. The resolution reaches 200
nm in the xy-plane and 500 nm in the z-plane. The greatest advantage is the possibility
of making 3D maps of the samples to within a depth of around 100–200 mm.
28.3.3 Micro-Computed Tomography (μCT)
Another technique used to analyze the tissue formation within the scaffolds is the
micro-computed tomography (micro-CT). Microtomography (or micro-computed
tomography, micro-computer tomography, X-ray tomographic microscopy, high res-
olution X-ray tomography) like computed tomography (CT), makes use of a X-ray
source to create shadow cross-section images/projections of a 3D object that later
can be used to recreate a virtual model without destroying the original object [10].
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The term micro is used to indicate that the pixel sizes of the cross-sections are in the
micrometer range. In general, there are two types of scanner setups. In one setup,
the X-ray source and detector are typically stationary during the scan while the sam-
ple/animal rotates. The second setup, much more like a clinical CT scanner, is gantry
based where the animal/specimen is stationary in space while the X-ray tube and
detector rotate around. These micro-CT scanners are typically used for small animals
imaging (e.g. bone, lung, cardiovascular, tumor and soft tissue), human samples (e.g.
skin and bone biopsies), electronic pieces and microdevices, plastic foams and com-
posite materials, wood and paper, microfossils and diamonds, and other studies for
which minute detail is desired [11].
28.4 CELL VIABILITY ASSAYS
Viability and proliferation of cells is an important parameter to consider when using
cell cultures. Viability assays are used to measure the proportion of viable cells after
a potentially traumatic procedure, such as primary disaggregation, cell separation,
or cryopreservation [12]. The net increase in the number of cells (i.e. the growth
yield) is labor intensive and time consuming to set up and analyze, particularly when
a large number of samples is involved, and the duration of each experiment may be
anywhere from 2 to 4 weeks. Instead, a number of alternatives have been devised for
assaying cells at higher densities, e.g. in microtitration plates. Indirect measurements
of viability are mainly based on metabolic activity. Indeed, the increase in the number
of cells is proportional to the increase in the total amount of protein or DNA, or
continued metabolic activity. In these cases, cell survival is defined by the retention
of metabolic ability by cell population, some time after removal of the toxic influence.
Cell viability can be determined by several tests, for example MTT, MTS or Ala-
mar Blue assay. One of the most used assays is the MTT test, based on the tetra-
zolium salt MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide),
that measures only living cells [13]. In this assay, the yellow tetrazole MTT is
reduced to purple formazan in living cells [13]. A solubilization solution is added
to dissolve the insoluble purple formazan product into a colored solution. Then, the
absorbance of this colored solution is quantified by measuring at a certain wavelength
(usually between 500 and 600 nm) by a spectrophotometer. The absorption maxi-
mum is dependent on the solvent employed [13]. Recent alternatives to the MTT
testing have been recently developed. Water-soluble tetrazolium salts were estab-
lished by introducing positive or negative charges and hydroxy groups to the phenyl
ring of the tetrazolium salt, or better with sulfonate groups added directly or indi-
rectly to the phenyl ring [14]. For example, WST-8 (2-(2-methoxy-4-nitrophenyl)-3-
(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium), has several advantages over
MTT, namely being reduced outside the cells and yielding a water-soluble formazan.
Moreover, WST assays can be read directly, giving a more accurate signal than MTT,
and present decreased toxicity to cells [14]. Scaffolds made of chitosan and starch
blends, with the ability to form a porous structure in situ, have been developed in our
group. The biocompatibility of the scaffolds was evaluated using extracts and direct
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contact tests. Results with the MTT test showed that materials extracts were clearly
non-toxic to L929 fibroblast cells [15].
Cell viability can be also determined by a colorimetric assay named CellTiter
96® AQueous One Solution Cell Proliferation Assay (Promega; USA). Briefly, this
assay is based on the bioreduction of a tetrazolium compound [3-(4,5-dimethyl-
thiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfofenyl)-2H-tetrazolium, inner
salt (MTS)] into a brown formazan product that is soluble in culture medium [16].
This conversion is accomplished by the production of NADPH or NADH by the
dehydrogenase enzymes existing in metabolically active cells. The quantity of
formazan product is directly proportional to the number of living cells in culture, as
measured by the amount of 490 nm absorbance in a microplate reader, after 3 h of
incubation at 37◦C.
Another well-known viability test in mammalian cell cultures is based on the
resazurin (7-Hydroxy-3H-phenoxazin-3-one 10-oxide) dye. It was introduced com-
mercially initially under Alamar Blue trademark (Trek Diagnostic Systems, Inc), and
now also available under other names such as AB assay, Vybrant (Molecular Probes)
and UptiBlue (Interchim). Resazurin is a non-toxic, cell permeable compound that
is blue in color and virtually non-fluorescent [17]. When it enters cells, it is irre-
versibly reduced to the pink colored and highly red fluorescent resorufin. Viable
cells continuously convert resazurin to resorufin, increasing the overall fluorescence
and color of the media surrounding cells. Resazurin based assays show excellent
correlation when compared to reference viability assays and tritiated thymidine based
techniques, while being much easier and safer to use for the user [18]. It also allows
for longer studies (minimally toxic to living cells), works for adherents cells and bac-
teria/fungi and can be multiplexed with several chemiluminescent assays, such as
cytokine assays, caspase assays to measure apoptosis, or reporter assays to measure
a gene or a protein expression [18].
One of the first steps in a TE approach is to determine the scaffolds cytotoxic-
ity. Chitosan-based scaffolds have been produced by melting and compression tech-
nologies and their cytotoxicity has been accessed. Standard tests (accordingly to
ISO/EN 10993 part 5 guidelines), namely MTS test with a 24-h extraction period,
have been performed, revealing that L929 cells had comparable metabolic activities
to that obtained for the negative control [19]. Moreover, direct-contact assays were
performed in these structures and it was shown that cells were able to colonize the
scaffolds, showing high levels of viability [20].
28.5 CELL PROLIFERATION ASSAYS
Cell proliferation can be assessed indirectly by quantifying its metabolic activity.
Measurements of DNA synthesis are often taken to be representative of the amount
of cell proliferation [12]. Cell proliferation rates determination is often used to deter-
mine the response of cells to a particular stimulus, i.e. physical (e.g. topography of
a substrate) or chemical (i.e. toxin or growth/differentiation factor). The most com-
monly used technique for measuring nucleic acid concentration is the determination
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of absorbance at 260 nm (A260). The major disadvantages of the absorbance method
are the large relative contribution of RNA and single-stranded DNA to the signal, the
interference caused by contaminants commonly found in nucleic acid preparations,
the inability to distinguish between DNA and RNA, and the relative insensitivity of
the assay (an A260 of 0.1 corresponds to a 5 μg/mL double-stranded DNA solution).
Alternatively, DNA content may be assayed by several fluorescence methods, includ-
ing reaction with DAPI, PicoGreen or Hoechst 33258. The fluorescence emission of
Hoechst 33258 at 458 nm is increased by interaction of the dye with DNA at pH 7.4
and in high salt to dissociate the chromatin protein [21]. This method gives a sen-
sitivity of 10 ng/mL, but requires intact double-stranded DNA. For examples, The
PicoGreen® dsDNA assay allows the detection of double stranded DNA, where the
number of cells is directly correlated with the quantity of protein or DNA present in
cells. Double-stranded DNA (dsDNA) is measured using an ultrasensitive fluorescent
nucleic acid stain [22], along the culturing time.
The fluorescent bisbenzimide (Hoechst) dyes are part of a family of blue fluo-
rescent dyes used to stain DNA [23]. Hoechst 33258 dye is relatively selective for
dsDNA and in high salt does not show fluorescent enhancement in the presence of
either protein or RNA. The dye binds specifically to the A-T base pairs in dsDNA
resulting in an increase in fluorescence and a shift in the emission maximum from
500 to 460 nm [24]. Hoechst 33258 is quenched by Bromodeoxyuridine (BrdU),
which is commonly used to detect dividing cells. Cells can integrate BrdU in newly
synthesized DNA as a substitute for thymidine. When BrdU is integrated into DNA,
it is supposed that the bromine deforms the minor groove so that Hoechst dyes cannot
reach their optimal binding site [25]. Hoechst dyes are often used as substitutes for
DAPI, because they are less toxic, which ensures a higher viability of stained cells.
Hoechst tests can be combined with other viability assays for an exhaustive cytotoxic
evaluation of a scaffold. For example, cryogelation technology was used to synthe-
size novel scaffolds from natural polymers like chitosan, agarose and gelatin and its
evaluation was performed using Hoechst, Alamar Blue and MTT tests [26].
The development of implantable scaffolds has several requirements. As stated
above, the toxicity evaluation is one of the main requirements that have to be pos-
itively filled in order to translate the technology for the clinics. Besides the cyto-
toxicity tests, the evaluation of other parameters such as the double stranded DNA
and total protein are very important. Recently, the cytotoxicity, DNA and protein
contents of ulvan extracted from green algae Ulva lactuca were quantified, resulting
in the conclusion that ulvan can be considered as non-toxic in the range of concen-
trations studied [27].
28.6 BIOCHEMICAL ANALYSIS
28.6.1 Glucose Consumption and Lactate Production
Glucose (C6H12O6) is a ubiquitous fuel molecule in biology [28]. It is oxidized
through a series of enzyme-catalyzed reactions to form carbon dioxide and water,
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yielding the universal energy molecule ATP. Due to its importance in metabolism,
glucose level is a significant parameter to be determined in cell culture [29], being
also a key diagnostic parameter for many metabolic disorders. Increased glucose lev-
els have been associated with diabetes mellitus, hyperactivity of thyroid, pituitary and
adrenal glands. Decreased levels are found in insulin secreting tumors, myxedema,
hypopituitarism and hypoadrenalism.
D-Glucose is phosphorylated to D-glucose-6-phosphate (G-6-P) in the presence of
the enzyme hexokinase (HK) and adenosine-5’-triphosphate (ATP) with the simulta-
neous formation of adenosine-5’-diphosphate (ADP):
D-Glucose + ATP
HK
⟶ G-6-P + ADP
In the presence of the enzyme glucose-6-phosphate dehydrogenase (G6P-DH),
G-6-P is oxidized by nicotinamide-adenine dinucleotide phosphate (NADP) to D-
gluconate-6-phosphate with the formation of reduced nicotinamideadenine dinu-
cleotide phosphate (NADPH):
G-6-P + NADP+
G6P-DH
−−−−−−−−−→ D-gluconate-6-phosphate + NADPH + H+
The amount of NADPH formed in this reaction is stoichiometric to the amount
of D-glucose. Therefore, the increase in NADPH could be measured by means of its
light absorbance at 334, 340 or 365 nm.
Lactate (CH3CH(OH)COO
-) plays important roles in many biological processes.
L(+)-Lactate is the major lactate stereoisomer formed in human intermediary
metabolism and is present in blood. D(–)-Lactate is also present but only at about
1–5% of the concentration of L(+)-Lactate. Abnormally high concentrations of lac-
tate have been related to disease states such as diabetes and lactic acidosis, etc.
In the presence of D-lactate dehydrogenase (D-LDH), D-lactic acid (D-lactate) is
oxidized to pyruvate by nicotinamide-adenine dinucleotide (NAD). The oxidation of
L-lactic acid requires the presence of the enzyme L-lactate dehydrogenase (L-LDH):
D-Lactase + NAD+
D-LDH
⟷ pyruvate + NADH + H+
L-Lactate + NAD+
L-LDH
⟷ pyruvate + NADH + H+
The equilibrium of these reactions lies on the side of lactate. By trapping pyruvate
in a subsequent reaction catalyzed by the enzyme glutamate pyruvate transaminase
(GPT) in the presence of L-glutamate, the equilibrium can be displaced in favor of
pyruvate and NADH:
Pyruvate + L-glutamate
GPT
⟷ L-alanine + 2-oxoglutarate
As for the glucose quantification, the amount of NADH formed in the above reac-
tions of Lactate is stoichiometric to the amount of D-lactic acid and of L-lactic acid,
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respectively [30]. Consequently, the increase in NADH could also be determined by
means of its light absorbance at 334, 340 or 365 nm.
28.6.2 Protein Synthesis
28.6.2.1 Total Protein Quantification
Total protein quantification is an important step for handling protein samples for iso-
lation and characterization [31]. Total cellular protein varies in relation to cell growth,
proliferation and differentiation [32–34]. Over the years, many different absorbance-
based colorimetricmethods have been developed to quantify protein, themost utilized
of which rely on the reduction of copper in the presence of a chromogenic reagent
[35, 36]. Examples of total protein colorimetric methods are: the Lowry method, the
bicinchoninic acid assay (BCA) and the biuret method [31]. While these methods
work well, they are subject to interference by many compounds commonly used in
protein purification, namely detergents and reducing agents. Alternatively, simple
absorbance measurements of protein solutions at 280 nm (A280) can be performed,
but are subject to interference from any nucleic acid contamination. In response to
these difficulties, dye-binding protein assays were developed, being the most com-
monly used the method described by Bradford. This assay is subject to the formation
of aggregates leading to a loss of signal over time. The most common procedures for
the quantification of total protein are colorimetric methods, which are fast and simple.
The Lowry Assay is a common method for quantitation of soluble protein [35].
Due to its sensitivity, simplicity, and precision, it is often a method of choice. Based
on two chemical reactions the first in which alkaline cupric tartrate complexes with
the peptide bond of the protein and the second a reduction with Folin and Ciocalteu’s
phenol reagent. This reaction yields a purple color in which the absorption is read
between 500 and 800 nm. This assay may be performed directly with a protein solu-
tion, or a precipitation method involving deoxycholate and trichloroacetic acid may
be used. Precipitation eliminates interference often caused by other reagents such as
Tris, ammonium sulfate, EDTA, sucrose, citrate, and others. Protein concentration
can then be determined using a calibration curve.
The principle of the bicinchoninic acid (BCA) assay is similar to the Lowry pro-
cedure, in that both rely on the formation of a Cu2+-protein complex under alkaline
conditions, followed by reduction of the Cu2+ to Cu1+ [31]. The amount of reduction
is proportional to the protein present. It has been shown that cysteine, cystine, tryp-
tophan, tyrosine, and the peptide bond are able to reduce Cu2+ to Cu1+. BCA forms
a purple-blue complex with Cu1+ in alkaline environments, thus providing a basis to
monitor the reduction of alkaline Cu2+ by proteins. The BCAAssay is more sensitive
and applicable than either biuret or Lowry procedures. In addition, it has less variabil-
ity than the Bradford assay. The BCA assay has many advantages over other protein
determination techniques: the color complex is stable; there is less susceptibility to
detergents; it is applicable over a broad range of protein concentrations.
The Bradford Assay can be also used to determine the concentration of proteins in
solution, consisting on the formation of a complex between the dye, Brilliant Blue G,
540 IN VITRO BIOLOGICAL TESTING IN THE DEVELOPMENT OF NEW DEVICES
and proteins. The protein–dye complex causes a shift in the absorption maximum
of the dye from 465 to 595 nm. The amount of absorption is proportional to the
protein present. The Bradford assay requires no dilution and is suitable for micro,
multiwell plate, and standard assays. The linear concentration range is 0.1–1.4 mg/ml
of protein, using BSA (bovine serum albumin) as the standard protein. The Bradford
assay is compatible with reducing agents, which are often used to stabilize proteins in
solution. Other protein assay procedures (Lowry and BCA) are not compatible with
reducing agents. The Bradford assay should be used in place of these protein assays
if reducing agents are present. However, the Bradford assay is only compatible with
low concentrations of detergents. If the protein sample to be assayed has detergents
present in the buffer, it is suggested to use the BCA protein determination procedure.
28.6.2.2 Enzyme-Linked Immunosorbent Assay
The enzyme-linked immunosorbent assay (ELISA) is a commonly used technique
for the determination of known analytes (e.g. proteins, peptides, hormones, etc.) [37].
ELISAs are routinely used in scientific research, veterinary medicine, environmental
and agricultural applications, and in healthcare [38]. The fundamental principle of
the ELISA is that the target analyte (the antigen) is recognized with high specificity
by antibodies, which are proteins produced by the immune system. These antibodies
can recognize and bind to the antigens, the labeling of the bound antibody forms the
basis of the detection.
The success of an ELISA assay is dependent upon the underlying level of
immunoreactivity of the capture and detection antibodies to the target analyte. Figure
28.2 shows one format of the assay, which uses two separate antibodies: the first to
recognize and bind the target analyte, the second to detect the bound target. In a first
step, one of the antibodies is applied to the well of a microtitre plate: this is known
as the capture antibody. The capture antibody binds to the plate via passive adsorp-
tion and this step is often performed at 4◦C overnight. A blocking solution, typically
milk protein (casein), bovine serum albumin or fish gelatin, is applied. These pro-
teins adhere to any vacant sites on the plastic surface of the well that are not occupied
by capture antibodies thereby minimizing the effect of nonspecific binding by other
RabMAb coated Microwells
Capture Ab
Target Protein
Detection Ab
Biotin
Streptavdin
HRP
TMB Substrate
FIGURE 28.2 Scheme of a typical ELISA. For a color version of this figure, see the color
plate section.
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reagents to the plate surface during subsequent incubation steps. Excess blocking
agent is removed and the plate is rinsed before addition of the test sample (wash steps
are incorporated between all incubation steps to minimize the background signal due
to nonspecific binding).
If the test sample contains the target analyte, this will be bound by the capture
antibody that is anchored to the plate (Step 2). After the incubation step with the
test sample, the plate is washed prior to the addition of the enzyme-linked detec-
tion antibody (Step 3). The detection antibody is conjugated with an enzyme, which
is commonly either horseradish peroxidase (HRP), alkaline phosphatase (AP) or
β-D-galactosidase. These enzymes are proteins that catalyze the hydrolysis of a
chromogenic substrate, such as 3,3’,5,5’-tetramethylbenzidine or 2,6- dichlorophe-
nolindophenol, which undergoes a colorimetric change that is measurable using a
spectrophotometric plate reader at specified wavelengths (Step 4). With the catalysis
of the traditional chromogenic substrates the reaction is terminated by the addition of
a stop solution prior to measuring the absorbance of each of the wells of the microtitre
plate.
In addition to the direct detection method, as illustrated in Figure 28.2, ELISAs
may utilize an indirect detection approach. In this instance, as illustrated in Step 5, the
secondary antibody used will recognize and bind to the appropriate species-specific
sub-class of the antibodies (or immunoglobulins). It is the secondary detection anti-
body that is conjugated to the enzyme, as opposed to the primary antibody. This
method offers versatility because a single enzyme labeled secondary detection anti-
body may be used for all assays involving the use of single host species of primary
antibodies. The sensitivity of the ELISA may also be enhanced as the secondary anti-
body tends to be polyclonal, and this affords signal amplification via the recognition
of multiple epitopes on the primary antibody.
28.7 GENOTYPIC EXPRESSION ANALYSIS
The determination of levels of gene expression in tissue engineered constructs is nor-
mally performed by several techniques that use extracted messenger ribonucleic acid
(RNA). Natural-based scaffolds present a challenge when considering attaining high
quality RNA for an efficient biological evaluation, as thesematerials interfere with the
most usually used RNA extraction techniques [39]. The majority of the commercial
RNA isolation kits are based on the use of an acid guanidinium thiocyanate-phenol-
chloroform extraction reagent, as first described by Chomczynki and Sacchi [40].
The TRIzol® family of reagents (Invitrogen, Carlsbad CA) is based on this method.
This reagent is ready-to-use for isolation of total RNA from cells and tissues. Tri-
zol disrupts cells and dissolves their components, while maintaining RNA integrity.
Then, chloroform is added, which allows the separation of the solution into two dis-
tinct phases: aqueous and organic. RNA will remain in the aqueous phase and it is
recovered by precipitation with isopropyl alcohol. When using natural polymers, the
large polysaccharide fragments present after the digestion can entrap nucleic acids,
while the small polysaccharides fragments can co-precipitate with the RNA in the
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precipitation step [39], leading to low RNA yields or interferences with the next anal-
ysis steps. Due to the high content in polysaccharides present in natural polymers,
these RNA extraction TRIzol-based methods and commercial kits have shown sev-
eral constrains in the isolation of quality RNA. Therefore, some researchers have been
developing cetyltrimethylammonium bromide (CTAB)–ammonium acetate protocols
for total RNA isolation from for example cotton [41] or from 3D chitosan, agarose
and collagen matrices [39].
Real-time PCR (RT-PCR) is a quantitative technique based in the Polymerase
Chain Reaction (PCR) procedure. PCR is a widely used technique that allows the
amplification of a copy of a DNA fragment millions of times amplifying its num-
ber to detectable quantities (amplicon). This technique relies on thermal cycling and
enzyme (DNA polymerase) replication of DNA. One major drawback of PCR is that
the amplicon can only be visualized when the reaction finishes. In RT-PCR this does
not happen, since this technique allows the amplification and simultaneous quantifi-
cation of the amplicon. RT-PCR is usually combined with reverse transcription to
quantify messenger RNA in cells or tissues. The difficulties in the RNA isolation that
were referred previously can affect the RT-PCR reaction because of the low qual-
ity of the isolated RNA. Nevertheless, researchers have managed to overcome these
difficulties and to perform this important technique in TE constructs for cartilage
[42, 43], bone [44], vascularization [45] and several other applications.
28.8 HISTOLOGICAL ASSESSMENT
Prior to sectioning, samples need to be processed. In the case of cells or tissues,
several embedding media are available for covering the structure and preserving its
integrity. Depending on the sample its characteristics, various embedding media can
be selected, such as paraffin, OCT compound or glycol methacrylate. The main dif-
ference between these media is on the processing technique. Paraffin samples are
processed using high temperatures (between 60–80◦C) whereas OCT samples are
processed in cold conditions using liquid nitrogen. Glycol methacrylate embedded
samples are processed using intermediate temperatures (4◦C). Some natural poly-
mers cannot stand the high temperatures used for paraffin processing, so the glycol
methacrylate technique is used, for example for processing chitosan-poly(butylene
terephthalate adipate) (CPBTA) scaffolds [46].
28.8.1 Hematoxylin–Eosin
Hematoxylin–eosin (H&E) staining is a method widely used for the analysis of cells
distribution and morphology. The combination of two stains (hematoxylin and eosin)
enables the detection of cell nuclei and cytoplasm. This stain can be performed to
evaluate the cells’ distribution within scaffolds. The next figure shows two exam-
ples of H&E stain of cells seeded onto natural-based scaffolds: compression molded
chitosan-PBS scaffolds (Fig. 28.3a) and starch-polycaprolactone (SPCL) electrospun
nanofiber meshes (Fig. 28.3b), seeded with bovine articular chondrocytes.
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(a) (b)
FIGURE 28.3 Bovine articular chondrocytes seeded onto natural-based scaffolds. (a)
Chitosan-PBS scaffold; (b) SPCL electrospun nanofiber mesh. For a color version of this fig-
ure, see the color plate section.
28.8.2 Immunodetection of Specific Proteins
Immunohistochemistry is a technique performed to detect and identify specific pro-
tein markers on in vitro cultures cells and in tissues. Particularly important in
defining the phenotype of the differentiating stem cells is an understanding of the
tissue development in relation to gene expression of the cells [47]. This technique pro-
vides in situ information of the localization of a specific protein, and has been devel-
oped from the antigen–antibody binding reaction [48]. Immunohistochemistry meth-
ods can be classified as immunofluorescence, immunoenzymological staining and
affinity histochemistry, depending on the different biotins conjugated with antibod-
ies. The immunofluorescence method relies on the antigen–antibody binding reac-
tion, where antigens are visualized by fluorescence dyes conjugated with antibodies,
when activated by exciting light of specific wavelength under fluorescence micro-
scope. The confocal microscope is often used to visualize samples stained with this
technique. Figure 28.4 shows human articular chondrocytes seeded onto a polycapro-
lactone (PCL)membrane, which surface has beenmodifiedwith chondroitin sulphate,
a natural component of cartilage ECM. The fluorescent dies enable to visualize the
cells morphology and arrangement in the scaffold.
In the immunoenzymological staining, enzyme-labeled antibodies are used to bind
specific antigens. Afterwards, an enzyme substrate is added in order to generate insol-
uble particles that can be localized under light microscope or electronic microscope.
This technique is considered to be more accurate in the localization of protein, as well
as presenting a better contrast ratio. Figure 28.5 shows the result of the immunolocal-
ization of collagen type II in a TE construct where bovine articular chondrocytes were
seeded and cultured under dynamic conditions using a rotator inside the incubator.
28.9 IN VITRO ENGINEERED TISSUES
28.9.1 Bone
Bone tissue engineering may constitute the needed breakthrough technology to
solve the problem of bone shortage in various destructive clinical conditions and
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FIGURE 28.4 Confocal microscopy images of hACs seeded onto CS-immobilized PCL
nanofiber meshes, at 21 days of culture. Cytoskeleton evidenced by phalloidin is shown in
red, nuclei are stained blue for DAPI and vinculin is stained green. For a color version of this
figure, see the color plate section.
(a)
100 μm 100 μm
(b)
FIGURE 28.5 Optical microscopy images presenting the results obtained from the
immunolocalization of collagen type II in histology sections of bovine articular chondro-
cytes seeded onto starch-compounded PCL nanofiber meshes cultured in dynamic conditions.
Images present results at 4 weeks of culture for normal goat serum – control (B), and collagen
type II (A). For a color version of this figure, see the color plate section.
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deformities, by providing functional tissue engineered biological substitute [49]. The
most used approach in the field is based on seeding and in vitro culture of autolo-
gous primary cells (osteoblasts or adult stem cells differentiated into the osteogenic
phenotype) on 3D scaffolds. These constructs will be further implanted into the
bone defect. The scaffold will provide the adequate 3D environment for cells to
adhere, proliferate and differentiate, while cells will synthesize ECM, producing bone
tissue.
Culture of osteogenic cells depends on the adequate supplementation of their
growth medium with a source of inorganic phosphate [50] – β-glycerophosphate,
a nonphysiological organic substrate of alkaline phosphatase (ALP) [51], in order
to produce mineralized ECM. Ascorbic acid is essential for the survival of human
osteoblasts in vitro [52]. This osteogenic inducing agent is required for collagen
synthesis and alkaline phosphatase activity [53]. Dexamethasone is a glucocorticoid
that increases the expression of several genes associated with osteogenic differentia-
tion [54]. Osteogenic differentiation process involves: (i) cell proliferation; (ii) ECM
deposition and maturation; and (iii) mineralization [55].
28.9.1.1 ALP Quantification
A thorough analysis of mineralization and the progression of differentiation rely on
biochemical assays. One of the most common used is the determination of the enzy-
matic activity of earlymarker ALP. HighALP activities are associated with active for-
mation of mineralized matrix, and highest levels are found in the mineralization front
in bone healing. Briefly, the activity of ALP was assessed using the p-nitrophenol
assay. Nitrophenyl phosphate disodium salt is colorless, and is hydrolyzed by alka-
line phosphatase, produced by cells, to form free p-nitrophenol, which is yellow. The
reaction is stopped by the addition of 2 M NaOH and the absorbance read at 405 nm.
Standards are prepared with p-nytrophenol solution, to obtain a standard curve. ALP
concentration is read off directly from the standard curve.
28.9.1.2 Mineralization Assessment
Total calcium content can also be quantified, by colorimetric or fluorimetric kits.With
the onset of mineralization, ECM protein genes become up-regulated, like osteopon-
tin and osteocalcin that are increasingly expressed with the accumulation of min-
eral [55]. The mineral content of the bone ECM can be qualitatively assessed by
alizarin red or von Kossa staining and the calcium content can be quantitatively
assessed. This information can be complemented by the analysis of the mineral frac-
tion by energy dispersive spectroscopy to detect the presence of calcium and phos-
phorous elements, thin-film X-ray diffraction to analyze the crystallinity of the ECM
and Fourier-transformed spectroscopy to detect the carbonate and phosphate groups
[56, 57].
Energy dispersive spectroscopy (EDS) methodology can be used to detect the
presence of calcium (Ca) and phosphorous (P) elements by analyzing the surface
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of the constructs. These two chemical elements are constituents of the mineral phase
(hydroxyapatite) of bone ECM. Their presence positively indicates the formation of
mineralized ECM at the surface of the constructs. Fourier transform infrared spec-
troscopy (FTIR) method is used to study the chemical structure of a polymer, but it
can also be used to analyze the chemical composition of the surface of a scaffold. In
bone tissue engineering, it can be used to confirm the results obtained from EDS anal-
yses, indicating the presence of phosphate and carbonate groups, which are typical
for carbonated apatite.
28.9.1.3 Specific Histological Stains
Von Kossa and Alizarin red are the most frequently used stains to detect the mineral-
ization process in osteoblast culture. Both stains are used to detect the mineralization,
but the reactions that generate a positive staining are different. In fact the Von Kossa
staining is based on a reaction of the silver nitrate that allows visualization of phos-
phate and carbonate anions that stain with a black color, while alizarin red S reacts
with calcium and other cations staining red [58] (Fig. 28.6). Von Kossa staining can
also react with other types of phosphate or carbonate salts, such as sodium phosphate
staining black and generating false positives. Therefore, the Von Kossa stain is not
specific for calcium, while alizarin red S reacts specifically with calcium and can
therefore be considered a more reliable stain to detect mineralization.
FIGURE 28.6 Alizarin red staining on mesenchymal stem cells differentiating to the
osteogenic lineage, at 14 days of culture, seeded onto nanofiber meshes. For a color version of
this figure, see the color plate section.
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28.9.2 Cartilage
28.9.2.1 Glycosaminoglycan Quantification
Adult articular cartilage is a hypocellular tissue, with a viscoelastic extracellular
matrix (ECM) composed mainly by water, collagens, glycosaminoglycan (GAG) –
bearing proteoglycans (aggrecan, biglycan, deocrin and fibromodulin), hyaluronic
acid and noncollagenous proteins (COMP, link). Quantitation of these components
can be performed by their solubilization through exhaustive proteolitic digestion.
Papain will fully solubilize GAG, by cleaving the core protein, and chondrocyte
DNA, by degrading nuclear binding proteins. Digestion at high temperatures (60◦C)
melts the collagen helix, thereby facilitating collagen proteolysis. The GAG content
can be measured by using a colorimetric assay such as the dimethyl methylene blue
(DMB) assay.
Glycosaminoglycan (GAG) quantification was based on the use of proteolytic
enzymes able to degrade cartilage ECM and a colorimetric assay tomeasure the quan-
tity of GAGs released [59]. Enzymes will degrade proteoglycans and the released
GAGs will be quantified indirectly. The basic die 1,9 dimethylmethylene blue will
link to the negatively charged GAGs and allow their detection by measuring the
solution absorbance. The quality of engineered cartilage and the amount of GAGs
deposited by bovine articular chondrocytes when seeded onto chitosan-based scaf-
folds have been quantified by this method [60].
28.9.2.2 Collagen Content Determination
Hydroxyproline is one of the main components of the collagen protein. The determi-
nation of the total collagen contents of a cartilage TE construct can be indirectly made
by measuring the hydroxyproline amount. The spectrophotometric-based hydrox-
yproline assay is one of the few assays for collagen content and concentration quan-
tification in several organs, including cartilage. This assay was described by Neu-
man and Logan (1950), and relies in the principle that all collagens contain globular
domains and share the common structural motif of triple helical segments [61]. Col-
lagen is one of the few proteins containing the amino acid hydroxyproline. Based on
the absolute quantitation of hydroxyproline, which represents a fixed percentage of
the amino acid composition of collagen in most mammalian tissues [62], the collagen
content may be derived. Since its description [61], this method has been altered by
several researchers in order to overcome some difficulties including its reproducibil-
ity between the same replicates, interferences by other components or differences in
standard curves [63]. One of the most frequently used methods that has been adapted
from the original is described by Bergman and Loxley [64]. Briefly, the collagen is
converted to a soluble form (gelatin), by hydrolysis under high temperatures, and
thus extracted from elastin and other substances that are not dissolved by the pro-
cess. The collagen content is then estimated from the hydroxyproline content of acid
hydrolysates of the extract [65].
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FIGURE 28.7 Examples of toluidine (a) and alcian blue (b) staining evidencing the cartilage
ECM deposited by bovine articular chondrocytes onto chitosan-based scaffolds, at 28 days of
culture. For a color version of this figure, see the color plate section.
28.9.2.3 Specific Histological Stain
Toluidine blue staining allows a metachromatic staining of cartilage matrix and
specifically of its proteoglycan content. It stains proteoglycans and GAGs (Fig.
28.7a). Alcian blue stain is used to detect cartilage formation. This dye stains acid
mucopolysacharides and GAGs (Fig. 28.7b). Safranin O staining is another technique
to detect cartilage components. This is a cationic dye that in dehydrated cartilage sec-
tions gets its orthochromatic form, and is in this form that safranin O links to tissues
GAGs.
28.10 CONCLUDING REMARKS
In vitro testing of biomaterials is essential for evaluation of cellular response to the
scaffolds or devices and is the first step towards its final application in vivo. Cytotoxi-
city tests comprise cells morphological analyses, response to extracts and direct con-
tact of cells and scaffolds. Evaluation of cell behavior when seeded onto the scaffolds
can be made by various techniques such as SEM, confocal microscopy, proliferation
assays, biochemical evaluation, histological stain or gene analysis. When working
with natural materials, researchers must be able to adapt some of the referred tech-
niques to the specificity of the biomaterials, as their high polysaccharide content may
influence the outcome of the analysis. By the end of a positive outcome, the natural
scaffold is then accepted to continue its evaluation in vivo.
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